ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |
Novo Holdings A/S | 1,126,915 | $5,183,809 | 0.38% |
ArrowMark Colorado Holdings LLC | 4,105,095 | $18,883,437 | 0.23% |
EPIQ Capital Group, LLC | 86,291 | $396,939 | 0.21% |
ArchPoint Investors | 115,055 | $529,253 | 0.20% |
Green Alpha Advisors, LLC | 39,364 | $181,074 | 0.14% |
PDT Partners, LLC | 210,076 | $966,350 | 0.12% |
Bridgefront Capital, LLC | 35,905 | $165,163 | 0.12% |
Baillie Gifford | 26,204,649 | $120,541,385 | 0.11% |
Duquesne Family Office | 659,750 | $3,035 | 0.11% |
DARK FOREST CAPITAL MANAGEMENT LP | 278,618 | $1,281,643 | 0.10% |
External links
This page lists ABCELLERA BIOLOGICS INC's shareholders in Q3 2023. To view ABCELLERA BIOLOGICS INC's shareholder history, click here.